In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.

They discuss:

• Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatigue
• Practical troubleshooting strategies for clinicians and patients

Sarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.

She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.

They discuss:

• How CGM improves maternal and neonatal outcomes

• Key clinical trials including the CONCEPTT trial

• Evolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)

Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.

They discuss:

• How AI and CGM technology is transforming diabetes and metabolic health management

• AI identification of diabetes subtypes and personalised interventions

• Impact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellness

• Potential of AI-driven tools for early intervention and improved health outcomes

Dr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.

To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.

They cover:

• The Role of AI in Continuous Glucose Monitoring

• Challenges and Potential of AI in Diabetes Management

• AI and CGM for Young People with Diabetes

• Potential for AI to instigate behaviour change

Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.

They explore a wide range of topics including:

• General challenges in managing diabetes
• Adjusting insulin doses for better control
• Time in tight range (TITR) and insulin management
• Fasting and diabetes management
• Impact of GLP-1 on Type 1 diabetes management
• Challenges of switching to weekly insulin injections
• Defining and managing hypoglycemia risk
• Personalized diabetes management approaches
• Diabetes management in athletes

Dr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.

They cover:

• Challenges and solutions in real-world insulin therapy

• How personalized strategies improve patient outcomes

• Lessons learned from patient-provider collaborations

• Future opportunities for enhancing patient engagement and adherence

• How to balance diabetes care with lifestyle choices

Christel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.

Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.

They cover:

• The latest clinical trials and guidelines

• New insulin formations

• Smart delivery technologies

• The potential of GLP-1 and GIP hormones

• Advice on lowering treatment burden and improving the quality of life for those living with diabetes

Lucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.

If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.

This is an accredited activity that gives you 1 CME/CPD credit.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.

They discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.

Dr. Egils Bogdanovics is an Assistant Clinical Professor of Medicine at the University of Connecticut. He’s Medical Director at the Charlotte Hungerford Hospital Diabetes Center, and a diplomate of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.

Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.

Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes care & technology.

Visit the Insulin Knowledge Hub on the Unlok Education website for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.

They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.

Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.

She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.

If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.